Literature DB >> 16865281

The expression of the carboxyl ester lipase gene in pancreas and pancreatic adenocarcinomas.

Reinhard Reuss1, Susanne Aberle, Karin Klingel, Martina Sauter, Annette Greschniok, Folker Ernst Franke, Winfried Padberg, Nikolaus Blin.   

Abstract

Since pancreatic cancer is an aggressive and often incurable malignancy, we investigated if the carboxyl ester lipase gene (CEL) is specifically expressed in pancreatic tissues and its promoter can be used for a specific suicide gene approach. Twenty-five tumor samples, 24 samples of normal pancreatic tissue and control tissues from other organs were examined by radioactive in situ hybridization (ISH) to localize CEL mRNA. Two carcinoma samples and 6 permanent cell lines were examined by reverse transcriptase-polymerase chain reaction (RT-PCR). By ISH, we verified a strong CEL gene expression in acinar cells of the normal pancreas. A minor expression was noted in a single sample of acinar cell carcinoma and adenocarcinomas did not show any expression. By RT-PCR, no specific expression in both tested adenocarcinomas was observed. In summary, these results show that, contrary to notable expression of carboxyl ester lipase in acinar cells of normal pancreatic tissue, this lipase is not significantly active in pancreatic adenocarcinomas and thus not an apt genetic marker for diagnostic or therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865281

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  The mucinous domain of pancreatic carboxyl-ester lipase (CEL) contains core 1/core 2 O-glycans that can be modified by ABO blood group determinants.

Authors:  Khadija El Jellas; Bente B Johansson; Karianne Fjeld; Aristotelis Antonopoulos; Heike Immervoll; Man H Choi; Dag Hoem; Mark E Lowe; Dominique Lombardo; Pål R Njølstad; Anne Dell; Eric Mas; Stuart M Haslam; Anders Molven
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

2.  Proteomic analysis of pancreatic intraepithelial neoplasia and pancreatic carcinoma in rat models.

Authors:  Lei Wang; Hai-Lin Liu; Ya Li; Ping Yuan
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

3.  Colonic carcinoma with a pancreatic acinar cell differentiation. A case report.

Authors:  Anna Maria Chiaravalli; Giovanna Finzi; Valentina Bertolini; Stefano La Rosa; Carlo Capella
Journal:  Virchows Arch       Date:  2009-11-12       Impact factor: 4.064

4.  The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.

Authors:  Stefano La Rosa; Francesca Franzi; Silvia Marchet; Giovanna Finzi; Moira Clerici; Davide Vigetti; Anna Maria Chiaravalli; Fausto Sessa; Carlo Capella
Journal:  Virchows Arch       Date:  2008-12-09       Impact factor: 4.064

5.  A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer.

Authors:  Stéphanie Durand; Killian Trillet; Arnaud Uguen; Aude Saint-Pierre; Catherine Le Jossic-Corcos; Laurent Corcos
Journal:  BMC Genomics       Date:  2017-09-30       Impact factor: 3.969

6.  Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers.

Authors:  Emmanuelle Martinez; Françoise Silvy; Fréderic Fina; Marc Bartoli; Martin Krahn; Fabrice Barlesi; Dominique Figarella-Branger; Juan Iovanna; René Laugier; Mehdi Ouaissi; Dominique Lombardo; Eric Mas
Journal:  Oncotarget       Date:  2015-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.